Odyssey Therapeutics Raises 279 Million in US IPO
Biopharmaceutical firm Odyssey Therapeutics raised 279 million dollars in an upsized US IPO. The company announced the results of the offering on Thursday.
Xurve View
Xurve View
Odyssey Therapeutics raised $279 million in an upsized initial public offering on Thursday. The offering was expanded from its initial target size. The upsized debut signals investor appetite for clinical-stage biotechnology firms.
